<code id='F2C527D506'></code><style id='F2C527D506'></style>
    • <acronym id='F2C527D506'></acronym>
      <center id='F2C527D506'><center id='F2C527D506'><tfoot id='F2C527D506'></tfoot></center><abbr id='F2C527D506'><dir id='F2C527D506'><tfoot id='F2C527D506'></tfoot><noframes id='F2C527D506'>

    • <optgroup id='F2C527D506'><strike id='F2C527D506'><sup id='F2C527D506'></sup></strike><code id='F2C527D506'></code></optgroup>
        1. <b id='F2C527D506'><label id='F2C527D506'><select id='F2C527D506'><dt id='F2C527D506'><span id='F2C527D506'></span></dt></select></label></b><u id='F2C527D506'></u>
          <i id='F2C527D506'><strike id='F2C527D506'><tt id='F2C527D506'><pre id='F2C527D506'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:6484
          green electrocardiogram scan. -- health tech coverage from STAT
          Adobe

          As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

          The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM —  provided funding and scientific input for the development of the algorithm.

          advertisement

          “BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          Boston's new lab space is opening empty
          Boston's new lab space is opening empty

          MichaelDwyer/APAroundthistimethreeyearsago,whilemostofus navigatedpandemiclife,realestatedevelopersa

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Amid AI frenzy, a top HHS official's quest to create safeguards

          MickyTripathiOfficeoftheNationalCoordinatorforHealthInformationTechnologyMickyTripathiisequalpartsex